Investor Presentation - First Six Months of 2021

96 Investor presentation First six months of 2021 GLP-1 market share and market growth in EMEA 80% 50% 20% -10% GLP-1 market growth and Novo Nordisk market share -40% May 2018 EMEA GLP-1 market size and growth 60% 69% DKK billion -25% 1 15 2 50% 0 57% 12 40% 32% 30% 25% ~32% 20% 56.8% 10% 53.8% 0% May 2021 May 2020 Novo Nordisk Eli Lilly Others May 2021 Novo Nordisk Competitors NN market share Market growth (right axis) -NN share of growth -NN growth (right axis) Source: IQVIA, May 2021, Value, MAT, Europe, Middle East & Africa; NN: Novo Nordisk

View entire presentation